A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps
Public ClinicalTrials.gov record NCT03280537. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Randomized, Multicenter, Double-blind, Placebo-controlled Clinical Trial of Omalizumab in Patients With Chronic Rhinosinusitis With Nasal Polyps
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the efficacy and safety of omalizumab compared with placebo in adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP) who have had an inadequate response to standard-of-care treatments. Study GA39688 (POLYP 1; NCT03280550) was another Phase III study by the Sponsor with identical objectives and design and was run in parallel with this study.
Study identification
- NCT ID
- NCT03280537
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 127 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 21, 2017 (Actual)
- Primary completion
- Mar 7, 2019 (Actual)
- Completion
- Mar 7, 2019 (Actual)
- Last update posted
- Mar 23, 2020
2017 – 2019
United States locations
- U.S. sites
- 16
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Center of Alabama, LLC | Birmingham | Alabama | 35209 | — |
| Banner University of Arizona Medical Center | Tucson | Arizona | 85724 | — |
| Kaiser Permanente - Rancho Cordova Medical Offices | Rancho Cordova | California | 95762 | — |
| Bensch Clinical Research LLC | Stockton | California | 95207 | — |
| Colorado ENT & Allergy | Colorado Springs | Colorado | 80909 | — |
| Specialist Global Research | Hialeah | Florida | 33012 | — |
| University of South Florida | Tampa | Florida | 33613 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Chesapeake Clinical Research Inc - CRN | Baltimore | Maryland | 21236 | — |
| Institute for Asthma & Allergy | Chevy Chase | Maryland | 20815 | — |
| Brigham and Womens Hospital | Boston | Massachusetts | 02115 | — |
| University of Missouri, ENT and Allergy Center of Missouri | Columbia | Missouri | 65212 | — |
| Allergy Associates Research Center LLC - CRN | Portland | Oregon | 97202 | — |
| TTS Research | Boerne | Texas | 78006 | — |
| Allergy & Asthma Res Ctr PA | San Antonio | Texas | 78251 | — |
| Eastern Virginia Medical School | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03280537, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 23, 2020 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03280537 live on ClinicalTrials.gov.